Zacks Investment Research on MSN

Is Bio-Rad a buy as digital PCR growth meets a premium valuation?

Bio-Rad Laboratories BIO is balancing improving digital PCR demand and a recurring diagnostics base against a valuation that ...
Seeking Alpha

Bio-Rad Laboratories, Inc. (BIO) Q4 2025 Earnings Call Transcript

Good day, everyone, and welcome to the Bio-Rad Fourth Quarter and Full Year 2025 Results Conference Call. At this time, I would like to hand things over to Mr. Edward Chung. Please go ahead, sir. Good ...